VBWG
Slides

CHICAGO trial: Carotid intima-media tHICkness in Atherosclerosis using pioGlitazOne



CHICAGO

Download VBWG06_%20CHICAGO.ppt (14 slides - 0.9MB)

CHICAGO CHICAGO: Background and rationale CHICAGO: Study design CHICAGO: Baseline demographics CHICAGO: Medical history CHICAGO: Baseline CV medications CHICAGO: Baseline risk factors CHICAGO: Treatment effect on posterior wall CIMT CHICAGO: Treatment effect on posterior wall CIMT in prespecified subgroups CHICAGO: Treatment effect on glucose control CHICAGO: Treatment effect on HDL-C CHICAGO: Adverse events CHICAGO: Summary CHICAGO: Implications


AtherosclerosisCarotidCHICAGOintimapioGlitazOnetHICkness

Related at vwbg.org

SECURE: ACE inhibition retards the progression of atherosclerosis

Final results of the Study to Evaluate Carotid Ultrasound changes with Ramipril and vitamin E (SECURE) have been published and confirm that treatment with ramipril 10 mg slows the progression of atherosclerosis, while treatment with vitamin E has no apparent effect.

Vascular Biology in Clinical Practice © Vol. 4, No. 5

The potential role of beta-blockade in blunting the progression of atherosclerosis

This monograph, The potential role of beta-blockade in blunting the progression of atherosclerosis , is offered as part of a series of continuing medical education programs from the University of Florida College of Medicine.
More related